Oppenheimer names Cepheid (CPHD +2.1%) as a Top Idea stock and reiterates its Outperform rating...
Oppenheimer names Cepheid (CPHD +2.1%) as a Top Idea stock and reiterates its Outperform rating on shares. Analysts with the firm call the molecular diagnostics company's technology platform "pioneering" with its ability to deliver results on tests for diseases to technicians within an hour.
From other sites
at Zacks.com (Mar 27, 2015)
at 4-traders.com (Mar 24, 2015)
at Investor's Business Daily (Jan 14, 2015)
at Nasdaq.com (Jan 6, 2015)
at Benzinga.com (Dec 18, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs